Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Cobiprostone for the Prevention of Severe Oral Mucositis in Subjects With Head and Neck Cancer (HNC)

NCT02542215 is registered in ClinicalTrials.gov with Sucampo Pharma Americas, LLC as lead sponsor.

NCT NCT02542215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02542215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Cobiprostone for the Prevention of Severe Oral Mucositis in Subjects With Head and Neck Cancer (HNC)
Lead sponsor
Sucampo Pharma Americas, LLC
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2015
Completion date
July 31, 2016
Enrollment
47 (actual)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis